However, some reports have shown that Rap2c can suppress the EMT process of colorectal cancer and inhibit cancer cell migration and metastasis in a nuclear factor κB- (NF-κB-) dependent pathway [69]. This evidence concerns the gene RAP2C and colorectal cancer.